Literature DB >> 11196708

A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene.

E E Nakayama1, C Wasi, A Ajisawa, A Iwamoto, T Shioda.   

Abstract

Interleukin 16 (IL-16) is a chemotactic cytokine which binds to CD4 and affects T cell activation. Here we report a novel single nucleotide polymorphism, T to C, in the promoter region of the IL-16 gene in two distinct Asian populations, Japanese and Thai. This mutation occurs at an allele frequency of approximately 22% and 18%, respectively. Although IL-16 potently suppresses replication of human immunodeficiency virus type 1 (HIV-1), we observed no significant difference in the allele frequency of this polymorphism between HIV-1-infected and non-HIV-1-infected individuals in both Asian populations. Since differential IL-16 levels have been reported to be associated with inflammatory diseases such as systemic lupus erythematosus, atopic dermatitis and allergic asthma, it would be of interest to analyze the allele frequency of this mutation in patients with these autoimmune and allergic diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11196708     DOI: 10.1038/sj.gene.6363672

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  10 in total

1.  -295 T-to-C promoter region IL-16 gene polymorphism is associated with Whipple's disease.

Authors:  F Biagi; A Schiepatti; C Badulli; I Sbarsi; L Trotta; G E Feurle; C Müller; V Moos; T Schneider; T Marth; M De Amici; M Martinetti; G R Corazza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-07-08       Impact factor: 3.267

2.  Prevalence of the -295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis.

Authors:  M Folwaczny; J Glas; H-P Török; L Tonenchi; E Paschos; O Malachova; B Bauer; C Folwaczny
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 3.  Hepatitis-related hepatocellular carcinoma: Insights into cytokine gene polymorphisms.

Authors:  Mahmoud Fathy Dondeti; Eman Anwar El-Maadawy; Roba Mohamed Talaat
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

Review 4.  Host factors influencing susceptibility to HIV infection and AIDS progression.

Authors:  Juan Lama; Vicente Planelles
Journal:  Retrovirology       Date:  2007-07-25       Impact factor: 4.602

5.  Genetic polymorphisms of interleukin-16 and risk of knee osteoarthritis.

Authors:  Shi-Xing Luo; Shan Li; Xue-Hui Zhang; Jun-Jing Zhang; Guang-Hua Long; Gui-Fu Dong; Wei Su; Yan Deng; Yanqiong Liu; Jin-Min Zhao; Xue Qin
Journal:  PLoS One       Date:  2015-05-08       Impact factor: 3.240

6.  Association of interleukin 16 gene polymorphisms and plasma IL16 level with osteosarcoma risk.

Authors:  Yu-Jin Tang; Jun-Li Wang; Ke-Gong Xie; Chang-Gong Lan
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

7.  Assessment of Interleukin 16 Serum Levels and Skin Expression in Psoriasis Patients in Correlation with Clinical Severity of the Disease.

Authors:  Dorota Purzycka-Bohdan; Aneta Szczerkowska-Dobosz; Monika Zablotna; Justyna Wierzbicka; Anna Piotrowska; Michal A Zmijewski; Boguslaw Nedoszytko; Roman Nowicki
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

8.  Interleukin-16 polymorphism is associated with an increased risk of ischemic stroke.

Authors:  Xiao-li Liu; Jian-zong Du; Yu-miao Zhou; Qin-fen Shu; Ya-guo Li
Journal:  Mediators Inflamm       Date:  2013-10-31       Impact factor: 4.711

9.  Association of IL-16 gene polymorphisms with the risk of developing type 2 diabetes mellitus in the Chinese Han population.

Authors:  Fangxiao Cheng; Lu Liu; Hongli Zhang; Yi Zhu; Xiaohua Li; Hong Li
Journal:  Biosci Rep       Date:  2019-08-15       Impact factor: 3.840

10.  Association of functional IL16 polymorphisms with cancer and cardiovascular disease: a meta-analysis.

Authors:  Victor Hugo de Souza; Josiane Bazzo de Alencar; Bruna Tiaki Tiyo; Hugo Vicentin Alves; Evelyn Castillo Lima Vendramini; Ana Maria Sell; Jeane Eliete Laguila Visentainer
Journal:  Oncotarget       Date:  2020-09-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.